VEGFA and acute myeloid leukemia: Patients with AML blasts expressing high levels of VEGF mRNA by quantitative polymerase chain reaction (PCR) had a significantly higher response rate and reduction of bone marrow MVD than patients with low VEGF expression consistent with the anti-angiogenic effects of SU5416.